TRXC robot surgery company, with unique laparoscopy technology called Senhance. You can see more on February 23. on a virtual conference. finance.yahoo.com
PT1: 6.5$ done
TOP: 6.95$
Between R1 (4.74) - MA20 (4.14) Moderated BUY, under 4.14 (blue arrow) Strong BUY and they also have some good news today.
finance.yahoo.com
PT2: 10.10$ /R4 - blue arrow/
The market atm is pretty boring. Bitcoin is doing nothing, stocks trading on news, Tesla mooning on earnings epectations with possibility of NASDAQ listing, cruise lines crap, and tech stocks booming. Now I been watching NSPR a little trying to find a good time to buy. NSPR is a medical stock that helps certain surgeries possible, yet its downfall is its not sold...
With brand recognition and consistent sales in place, Mazor has stated that 2018 will be a transition year for them, not growth. Therefore, expect the company to aim for stability as it continues to spread its products. Per the last call: "2018 is expected to be a year of transition and our performance is expected to be driven primarily by increased revenues from...
